Federal Research Institute Of Pediatric Hematology, Oncology And Immunology
Clinical trials sponsored by Federal Research Institute Of Pediatric Hematology, Oncology And Immunology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Immune booster: donor NK cells aim to stop leukemia return after transplant Results expected Oct 2026 (estimated)
- New hope for kids with aggressive nerve cancer: immune-boosting combo trial opens Results expected Dec 2026 (estimated)
- New cell cocktail aims to prevent transplant complications in kids with leukemia Results expected Jun 2027 (estimated)